Parkinson's Disease Trial, Recruiting NCT05822258 Sponsor: Rennes University Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05822258
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who have been diagnosed with Parkinson's disease based on a specific set of diagnostic standards known as the United Kingdom Brain Bank criteria
  • People who experience episodes of "freezing" while walking (where movement suddenly stops), rated at a moderate level on a standard Parkinson's assessment scale, meaning they can still walk without the help of a walking aid or other technical device
  • People who are able to walk 30 metres on their own without assistance
  • People who are enrolled in, or covered by, a French social security or health insurance scheme
  • People who have signed a written consent form agreeing to take part in the trial

Who may not be able to join:

  • People who score below 20 out of 30 on a standard memory and thinking assessment called the Montreal Cognitive Assessment (MoCA)
  • People who have another neurological condition (such as a brain or nerve disorder) or a bone/joint condition that affects the way they walk
  • Women who are pregnant, in labour, or breastfeeding
  • People who are under a legal protection order, or whose legal decision-making capacity is managed by a court or guardian
  • People who are currently receiving psychiatric care, or who are living in a health or social care facility for reasons unrelated to research
  • People under 18 years of age
  • People who are unable to give their own informed consent to participate
  • People who are already taking part in another research study involving balance and/or walking

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rennes University Hospital
Registry
ClinicalTrials.gov
Start date
8 January 2024
Est. completion
8 February 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Precision

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov